Cost-effectiveness of antihistaminics in adults’ patients with allergic rhinitis
In this cost-utility analysis of oral H1 antihistamines for adults with intermittent allergic rhinitis in Colombia, cetirizine 10 mg and fexofenadine 180 mg emerged as the cost-effective options, offering high net monetary benefits and remaining undominated in deterministic and probabilistic analyses.
Authors
- Diana Guerrero Patiño (ORCID: https://orcid.org/0000-0001-7731-4460)
- Jefferson Antonio Buendia
Institutions
- Universidad de Antioquia (CO)
Publication Details
- Journal
- Cost Effectiveness and Resource Allocation
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1186/s12962-025-00688-8
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00